RNA-binding proteins potentially regulate the alternative splicing of apoptotic genes during knee osteoarthritis progression
Authors:
Open Access
- 19 March 2024
- journal article
- research article
- Published by Springer Nature in BMC Genomics
- Vol. 25 (1) , 1-13
Abstract
Background: Alternative splicing (AS) is a principal mode of genetic regulation and one of the most widely used mechanisms to generate structurally and functionally distinct mRNA and protein variants. Dysregulation of AS may result in aberrant transcription and protein products, leading to the emergence of human diseases. Although considered important for regulating gene expression, genome-wide AS dysregulation, underlying mechanisms, and clinical relevance in knee osteoarthritis (OA) remain unelucidated. Therefore, in this study, we elucidated and validated AS events and their regulatory mechanisms during OA progression. Results: In this study, we identified differentially expressed genes between human OA and healthy meniscus samples. Among them, the OA-associated genes were primarily enriched in biological pathways such as extracellular matrix organization and ossification. The predominant OA-associated regulated AS (RAS) events were found to be involved in apoptosis during OA development. The expression of the apoptosis-related gene BCL2L13, XAF1, and NF2 were significantly different between OA and healthy meniscus samples. The construction of a covariation network of RNA-binding proteins (RBPs) and RAS genes revealed that differentially expressed RBP genes LAMA2 and CUL4B may regulate the apoptotic genes XAF1 and BCL2L13 to undergo AS events during OA progression. Finally, RT-qPCR revealed that CUL4B expression was significantly higher in OA meniscus samples than in normal controls and that the AS ratio of XAF1 was significantly different between control and OA samples; these findings were consistent with their expected expression and regulatory relationships. Conclusions: Differentially expressed RBPs may regulate the AS of apoptotic genes during knee OA progression. XAF1 and its regulator, CUL4B, may serve as novel biomarkers and potential therapeutic targets for this disease.Keywords
This publication has 53 references indexed in Scilit:
- Roles of RNA-binding proteins in neurological disorders, COVID-19, and cancerHuman Cell, 2022
- Ageing and Osteoarthritis2019
- Transcriptome‐Wide Analysis Reveals the Landscape of Aberrant Alternative Splicing Events in Liver CancerHepatology, 2018
- Roles for RNA-binding proteins in development and diseaseBrain Research, 2016
- Comprehensive Identification of RNA-Binding Proteins by RNA Interactome Capture2016
- XIAP‐associated factor 1 (XAF1), a novel target of p53, enhances p53‐mediated apoptosis via post‐translational modificationMolecular Carcinogenesis, 2011
- Alternative splicing and diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Alternative Splicing: New Insights from Global AnalysesCell, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Osteoarthritis chondrocytes die by apoptosis: A possible pathway for osteoarthritis pathologyArthritis & Rheumatism, 1998